Bilateral and Unilateral Horizontal Strabismus Surgery

This study was done in alternating strabismus patients to compare symmetrical muscle surgery and asymmetrical one as regard efficacy and lateral incomitance after surgery

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Strabismus Cranial Nerve Diseases Eye Diseases Nervous System Diseases Ocular Motility Disorders

Age range

4 year–28 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Medicine, Minya, Minya Governorate, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

more than 3 years old.
alternating esotropia or exotropia

Exclusion criteria

unilateral strabismus
paralytic or restrictive strabismus

Treatment and study plan

symmetrical and asymmetrical horizontal strabismus surgery

Procedure

surgery was done on the medial rectus muscle on both eyes, lateral rectus muscle in both eyes or medial and lateral rectus muscle in one eye

Primary outcomes

There was 95% success rate in asymmetrical group compared with 90% in symmetrical one

Time frame: one and half year

This result was measured by simultaneous prism cover test and expressed in prism diopter

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Official study title

Assessment of Symmetrical and Asymmetrical Horizontal Strabismus Surgery: Efficacy and Lateral Incomitance

Important dates

Study start: 2019
Primary completion: 2021
Study completion: 2021
First posted: Dec 13, 2019
Registry last updated: Jun 18, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed